Adaptive Biotechnologies Corp (ADPT) insider trading

By person

29 insiders · 978 transactions

81.1×

Chad Robins holds 81.1 times base salary in stock. $56.65M of shares against $698.26K in salary for 2025.

Salary from the company's own proxy. The shares are what Chad Robins last reported holding, valued at $25.98, the price Common Stock was last bought or sold at on the open market here, on 3 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Viking Global Investors LP entity

10% owner

$5.00M (1)

$302.14M (3)

−$297.14M

29,993,708

18.79%

$779.24M

+2,005%

Viking Global Performance LLC entity

10% owner

$5.00M (1)

$246.49M (2)

−$241.49M

30,993,708

19.42%

$805.22M

+2,075%

David E. Goel

Director

—

$112.23M (10)

−$112.23M

12,310,594

7.71%

$319.83M

—

Julie Rubinstein

President and COO

—

$89.66M (239) scheduled

−$89.66M

377,802

0.2367%

$9.82M

—

Chad M Robins

CEO and Chairman

—

$89.34M (160) scheduled

−$89.34M

2,180,518

1.37%

$56.65M

+19.3%

Harlan S Robins

Chief Scientific Officer

—

$63.17M (153) scheduled

−$63.17M

812,058

0.5088%

$21.10M

—

Chad M Cohen

Chief Financial Officer

$20.00K (1)

$47.01M (81) scheduled

−$46.99M

21,604

0.0135%

$561.27K

—

Sharon Benzeno

Chief Commercial Ofc Imm Med

—

$29.75M (50) scheduled

−$29.75M

221,278

0.1386%

$5.75M

—

Francis Lo

Chief People Officer

—

$16.68M (42) scheduled

−$16.68M

223,367

0.1400%

$5.80M

+8,835%

Nancy Louise Hill

EVP, Operations & Program Mana

$224.00K (4)

$11.38M (11) scheduled

−$11.15M

10,300

0.0065%

$267.59K

−77.2%

Andris A Zoltners

Director

—

$9.14M (1) scheduled

−$9.14M

3,621,016

2.27%

$94.07M

—

Lance Baldo

Chief Medical Officer

—

$7.43M (25) scheduled

−$7.43M

17,171

0.0108%

$446.10K

—

Charles Sang

SVP, External Affairs

—

$6.49M (4) scheduled

−$6.49M

0.0000%

$0.00

—

Michelle Renee Griffin

Director

—

$5.88M (25) scheduled

−$5.88M

15,625

0.0098%

$405.94K

—

Michael J Pellini

Director

—

$5.27M (4) scheduled

−$5.27M

69,690

0.0437%

$1.81M

—

Stacy L Taylor

SVP and General Counsel

—

$4.79M (40) scheduled

−$4.79M

139,365

0.0873%

$3.62M

+10,620%

Kyle Piskel

Chief Financial Officer

—

$3.74M (17) scheduled

−$3.74M

256,725

0.1609%

$6.67M

—

Susan Bobulsky

Chief Commercial Officer, MRD

—

$3.50M (15) scheduled

−$3.50M

389,350

0.2440%

$10.12M

+226.8%

Robert Hershberg

Director

—

$3.42M (25) scheduled

−$3.42M

46,683

0.0293%

$1.21M

—

Peter M Neupert

Director

—

$3.21M (4) scheduled

−$3.21M

130,625

0.0818%

$3.39M

—

Eric Dobmeier

Director

—

$2.11M (11) scheduled

−$2.11M

1,504

0.0009%

$39.07K

—

Tycho Peterson

Chief Financial Officer

—

$2.02M (6) scheduled

−$2.02M

531,553

0.3331%

$13.81M

—

R Mark Adams

Chief Operating Officer

—

$1.66M (20)

−$1.66M

175,361

0.1099%

$4.56M

—

Jyoti Palaniappan

SVP, Diagnostics, T-Detect

—

$877.35K (8) scheduled

−$877.35K

9,158

0.0057%

$237.92K

—

Nitin Sood

Chief Commercial Officer, MRD

—

$689.91K (6)

−$689.91K

214,808

0.1346%

$5.58M

—

Katey Einterz Owen

Director

—

$249.99K (1)

−$249.99K

66,100

0.0414%

$1.72M

—

Henning Thorsen

SVP, Commercial Operations

—

29,061

0.0182%

$755.00K

—

Leslie Trigg

Director

—

25,907

0.0162%

$673.06K

—

Kevin T Conroy

Director

—

22,968

0.0144%

$596.71K

—

Adaptive Biotechnologies Corp

What the insiders did Net selling

By person